- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
JB Chemicals launches chatbot Dr Will, NOSMOK nicotine lozenges to help quit smoking
NOSMOK nicotine lozenges will help reduce the urge to consume or smoke tobacco and relieve the psychological and psychomotor withdrawal symptoms, thus helping such people in their tobacco cessation journey, J B Chemicals & Pharmaceuticals said in a statement.
New Delhi: J B Chemicals & Pharmaceuticals on Monday said it has launched medicated nicotine lozenges that will help reduce the urge to consume or smoke tobacco.
On the occasion of ''World No Tobacco Day'', the drugmaker has also launched an Artificial Intelligence-enabled chatbot ''Dr Will'', which would encourage and support tobacco smokers to quit smoking.
NOSMOK nicotine lozenges will help reduce the urge to consume or smoke tobacco and relieve the psychological and psychomotor withdrawal symptoms, thus helping such people in their tobacco cessation journey, J B Chemicals & Pharmaceuticals said in a statement.
The medicated nicotine lozenges will be available in mint flavour as sugar-based and sugar-free variants in 2mg and 4mg strengths.
The lozenges are a part of the company's global portfolio which are being introduced in the country.
"India''s death burden and the economic costs from tobacco usage are unacceptably high and it is critical that we address this issue. Studies indicate that over 55 per cent of tobacco users are willing to quit all forms of tobacco.
"However, quitting tobacco is a challenge, especially with the added social and economic stresses because of the pandemic," JB Chemicals & Pharmaceuticals CEO & Whole Time Director Nikhil Chopra said.
A study sanctioned by the company has revealed that a successful tobacco cessation initiative would require not just nicotine replacement therapy but also patient education and support through the journey to quit smoking, he added.
"This has led to our launching nicotine replacement pharmacotherapy, NOSMOK accompanied by a digital AI-enabled WhatsApp based chatbot, ''Dr Will''. We are confident that these will help tobacco users and smokers to successfully beat their habit and emerge tobacco-free," Chopra noted.
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751